RECENT NEWS
SeekingAlpha  Oct 17  Comment 
By Don Dion: Xenon Pharmaceuticals (Pending:XENE) recently filed with the Securities and Exchange Commission (SEC) for an IPO with plans to list on NASDAQ. At a target high of $12 for 4 million + shares, the company can potentially raise nearly...
Benzinga  Oct 16  Comment 
Portola Pharmaceuticals (Nasdaq: PTLA) today announced that it has executed a supply agreement with Lonza for the commercial manufacturing of andexanet alfa. An FDA-designated breakthrough therapy, andexanet alfa is the only recombinant Factor Xa...
SeekingAlpha  Oct 16  Comment 
By Christopher F. Davis: RXi Pharmaceuticals (OTC:RXII) has just filed a form 4 with the Securities Exchange Commission. Recall that a form 4 refers to insider transactions at the company. Well, at RXi, there has been a wave of insider buying by...
SeekingAlpha  Oct 16  Comment 
By IPOdesktop: Based in Burnaby, British Columbia, Canada, Xenon Pharmaceuticals (Pending:XENE) scheduled a $44 million IPO on the Nasdaq with a market capitalization of $149 million at a price range midpoint of $12 for Friday, Oct. 17, 2014. The...
The Hindu Business Line  Oct 15  Comment 
Elder Pharmaceuticals today said it has entered into fast—growing Rs 600-crore market size Indian mouthwash category in oral care segment, where the company is eyeing 5-7 per cent share in the next...
Benzinga  Oct 15  Comment 
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced the initiation of four expansion cohorts in its ongoing Phase 1 study of AG-221, a first-in-class,...
Financial Times  Oct 15  Comment 
UK pharmaceuticals group’s shares tumble
StreetInsider.com  Oct 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Dicerna+Pharmaceuticals+%28DRNA%29+Presents+Preclinical+Data+for+Investigational+RNAi+Therapeutic+DCR-PH1/9910349.html for the full story.
SeekingAlpha  Oct 14  Comment 
By Kanak Kanti De: Every year an estimated 12 million people are diagnosed with cancer globally. According to the International Agency for Research on Cancer or IARC, by 2030, the number of people diagnosed with cancer annually will increase to...
StreetInsider.com  Oct 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Supernus+Pharmaceuticals+%28SUPN%29+Receives+Paragraph+IV+Notice+for+Generic+Trokendi+XR/9908012.html for the full story.




 

This is a list of sub-industries in the pharmaceuticals industry, and a list of their member companies



Drug Delivery

Drug Manufacturers - Major

Drug Manufacturers - Other

Drug Related Products

Biotechnology

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki